NPC1L1 exon 2 amino acid mutations identified in an exceptional ezetimibe responder.
Molecular modeling showed altered cholesterol entry and cholesterol binding.
Amino acid changes reduced cholesterol uptake when ezetimibe was present.
Major amino acids changes involved are L52P and I300T.
NPC1L1 protein:protein interactions are altered.